__timestamp | Pharming Group N.V. | Vericel Corporation |
---|---|---|
Wednesday, January 1, 2014 | 4167274 | 17293000 |
Thursday, January 1, 2015 | 5247851 | 26470000 |
Friday, January 1, 2016 | 4925118 | 28307000 |
Sunday, January 1, 2017 | 14930297 | 30354000 |
Monday, January 1, 2018 | 25371768 | 32160000 |
Tuesday, January 1, 2019 | 23921274 | 37571000 |
Wednesday, January 1, 2020 | 25338236 | 39951000 |
Friday, January 1, 2021 | 20182966 | 50159000 |
Saturday, January 1, 2022 | 17562000 | 54577000 |
Sunday, January 1, 2023 | 25212000 | 61940000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, understanding cost dynamics is crucial. From 2014 to 2023, Pharming Group N.V. and Vericel Corporation have shown distinct trends in their cost of revenue. Pharming Group N.V. started with a modest cost of revenue, peaking in 2018 at approximately 25 million, before stabilizing around 20 million in recent years. In contrast, Vericel Corporation's cost of revenue has consistently risen, starting at 17 million in 2014 and reaching a significant 62 million by 2023. This represents a staggering 260% increase over the decade. Such insights highlight Vericel's aggressive growth strategy, while Pharming's cost management reflects a more conservative approach. As the pharmaceutical industry continues to expand, these trends offer a glimpse into the strategic priorities of these companies, providing valuable insights for investors and industry analysts alike.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Vericel Corporation
Analyzing Cost of Revenue: Vertex Pharmaceuticals Incorporated and Pharming Group N.V.
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Vericel Corporation
Cost of Revenue Comparison: BeiGene, Ltd. vs Vericel Corporation
United Therapeutics Corporation vs Pharming Group N.V.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Intra-Cellular Therapies, Inc. vs Pharming Group N.V.
Analyzing Cost of Revenue: Pharming Group N.V. and Telix Pharmaceuticals Limited
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs Agios Pharmaceuticals, Inc.
Pharming Group N.V. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Pharming Group N.V. vs BioCryst Pharmaceuticals, Inc.
Cost of Revenue Trends: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Vericel Corporation vs Geron Corporation: Efficiency in Cost of Revenue Explored